![](/img/cover-not-exists.png)
PCN524 EUROPEAN REAL-WORLD TREATMENT PATTERNS OF SYSTEMIC THERAPIES FOR SECOND LINE (2L) HEPATOCELLULAR CARCINOMA (HCC) PATIENTS WHO PREVIOUSLY RECEIVED SORAFENIB
Kiiskinen, U., Rider, A., Leith, A., Khela, K., Girvan, A., Nitu, I., Senin, T., Jen, M.H.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.715
Date:
November, 2019
File:
PDF, 712 KB
2019